-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Eagle Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2022.
- Eagle Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was -$1.01M, a 87.5% increase year-over-year.
- Eagle Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was -$11.8M, a 32% increase year-over-year.
- Eagle Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$19.5M, a 167% decline from 2021.
- Eagle Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$7.32M, a 28.8% increase from 2020.
- Eagle Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was -$10.3M, a 5716% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)